{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"FDA puts Regenxbio's Hunter syndrome gene-therapy trial on hold","author_name":"techandbusiness.org · Policy","thumbnail_url":"https://static.biospace.com/dims4/default/f5b9f57/2147483647/strip/true/crop/724x407+0+38/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F5d%2Fac%2F347a790a4e478c197afb5ace5312%2Fdominoes.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Policy</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/GRV4Nkpgg_bsHvIbaii8eB\" style=\"color:#fff;text-decoration:none;\">FDA puts Regenxbio's Hunter syndrome gene-therapy trial on hold</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">The FDA placed a clinical hold on REGENXBIO's RGX-121 trial after MRI scans found small nodules or cystic masses in the spines of five of 48 participants in the CAMPSIITE study, according to the compa...</p>\n    </blockquote>"}